Apoptotic circulating tumor cells (CTCs) in the peripheral blood of metastatic colorectal cancer patients are associated with liver metastasis but not CTCs

Oncotarget

Volumn 5, Issue 7, 2014, Pages 1753-1760

  Allen, Joshua E ^a   Saroya, Bikramajit Singh ^a   Kunkel, Miriam ^a   Dicker, David T ^a   Das, Avisnata ^a   Peters, Kristi L ^a   Joudeh, Jamal ^a   Zhu, Junjia ^a   El Deiry, Wafik S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Colon cancer; Colorectal cancer; CTC; Metastasis; Prognostic marker

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER PATIENT; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; LIVER METASTASIS; LUNG METASTASIS; MALE; METASTATIC COLORECTAL CANCER; PROGNOSIS; TUMOR INVASION; VERY ELDERLY; BLOOD; CELL COUNT; COLORECTAL TUMOR; LIVER TUMOR; LUNG TUMOR; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; SECONDARY; TUMOR EMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOEMBRYONIC ANTIGEN; CELL COUNT; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING;

EID: 84898987182     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1524     Document Type: Article

References (17)

1. Siegel R, Naishadham D and Jemal A. Cancer statistics, 2012. CA: A Cancer Journal for Clinicians. 2012; 62(1):10-29.
2. Cohen SJ, Punt CJA, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC, Doyle GV, Tissing H, Terstappen LWMM and Meropol NJ. Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer. J Clin Oncol. 2008; 26(19):3213-3221.
3. Cohen SJ, Punt CJA, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse MA, Mitchell E, Miller MC, Doyle GV, Tissing H, Terstappen LWMM and Meropol NJ. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Annals of Oncology. 2009; 20(7):1223-1229.
4. Allen JE and El-Deiry WS. Circulating Tumor Cells and Colorectal Cancer. Current Colorectal Cancer Reports. 2010; 6(4):212-220.
5. Thiery JP and Lim CT. Tumor Dissemination: An EMT Affair. Cancer cell. 2013; 23(3):272-273.
6. Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, Concannon KF, Donaldson MC, Sequist LV, Brachtel E, Sgroi D, Baselga J, et al. Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition. Science. 2013; 339(6119):580-584.
7. Hou J-M, Krebs M, Ward T, Sloane R, Priest L, Hughes A, Clack G, Ranson M, Blackhall F and Dive C. Circulating Tumor Cells as a Window on Metastasis Biology in Lung Cancer. The American Journal of Pathology. 2011; 178(3):989-996.
8. Molnar B, Ladanyi A, Tanko L, Sreter L and Tulassay Z. Circulating Tumor Cell Clusters in the Peripheral Blood of Colorectal Cancer Patients. Clinical Cancer Research. 2001; 7(12):4080-4085.
9. Hou J-M, Krebs MG, Lancashire L, Sloane R, Backen A, Swain RK, Priest LJC, Greystoke A, Zhou C, Morris K, Ward T, Blackhall FH and Dive C. Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer. Journal of Clinical Oncology. 2012; 30(5):525-532.
10. Scholtens TM, Schreuder F, Ligthart ST, Swennenhuis JF, Greve J and Terstappen LWMM. Automated identification of circulating tumor cells by image cytometry. Cytometry Part A. 2012; 81A(2):138-148.
11. Patel A, Allen J, Dicker D, Peters K, Sheehan J, Glantz M and El-Deiry W. Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases. Oncotarget. 2011; 2:752 - 760.
12. Le Rhun E, Massin F, Tu Q, Bonneterre J, Bittencourt MDC and Faure G. Development of a new method for identification and quantification in cerebrospinal fluid of malignant cells from breast carcinoma leptomeningeal metastasis. BMC Clinical Pathology. 2012; 12(1):21.
13. Iinuma H, Watanabe T, Mimori K, Adachi M, Hayashi N, Tamura J, Matsuda K, Fukushima R, Okinaga K, Sasako M and Mori M. Clinical Significance of Circulating Tumor Cells, Including Cancer Stem-Like Cells, in Peripheral Blood for Recurrence and Prognosis in Patients With Dukes' Stage B and C Colorectal Cancer. Journal of Clinical Oncology. 2011; 29(12):1547-1555.
14. Faltas B, Zeidan A, Peters K, Das A, Joudeh J, Navaraj A, Dolloff NG, Harvey HA, Jiang Y, Allen JE, Dicker DT and El Deiry WS. Identifying Circulating Tumor Stem Cells That Matter: The Key to Prognostication and Therapeutic Targeting. Journal of Clinical Oncology. 2011; 29(21):2946-2947.
15. Ignatiadis M, Rothe Fo, Chaboteaux C, Durbecq V, Rouas G, Criscitiello C, Metallo J, Kheddoumi N, Singhal SK, Michiels S, Veys I, Rossari J, Larsimont D, Carly B, Pestrin M, Bessi S, et al. HER2-Positive Circulating Tumor Cells in Breast Cancer. PLoS ONE. 2011; 6(1):e15624.
16. Riethdorf S, Muller V, Zhang L, Rau T, Loibl S, Komor M, Roller M, Huober J, Fehm T, Schrader I, Hilfrich Jr, Holms F, Tesch H, Eidtmann H, Untch M, von Minckwitz G, et al. Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial. Clinical Cancer Research. 2010; 16(9):2634-2645.
17. Dawson S-J, Tsui DWY, Murtaza M, Biggs H, Rueda OM, Chin S-F, Dunning MJ, Gale D, Forshew T, Mahler-Araujo B, Rajan S, Humphray S, Becq J, Halsall D, Wallis M, Bentley D, et al. Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer. New England Journal of Medicine. 2013; 368(13):1199-1209.